China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
29.23
+0.10 (0.34%)
At close: Feb 6, 2026

SHA:600511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7,72710,88610,9268,8967,3046,225
Trading Asset Securities
----11.4-
Cash & Short-Term Investments
7,72710,88610,9268,8967,3166,225
Cash Growth
-6.88%-0.36%22.81%21.60%17.53%9.16%
Accounts Receivable
17,02113,93112,88112,55013,39212,507
Other Receivables
316.67199.01204389.6979.93129.77
Receivables
17,33814,13013,08512,94013,47212,637
Inventory
5,1634,9563,9613,7173,5153,050
Other Current Assets
301.6385.73307.79210.44280.62198.65
Total Current Assets
30,52930,35728,27925,76424,58422,110
Property, Plant & Equipment
800.94878.6827.04857.91845.06895.73
Long-Term Investments
2,3572,1761,9071,6231,3651,141
Goodwill
203.77203.77203.77203.77203.77203.77
Other Intangible Assets
254.06276.76258.11262.92258.65256.12
Long-Term Deferred Tax Assets
145.98149.07123.87124.37115.94100.6
Long-Term Deferred Charges
146.78152.39150.0686.1989.690.31
Other Long-Term Assets
687.92734.85703.57686.95548.08108.13
Total Assets
35,12534,92832,45329,60928,01024,905
Accounts Payable
11,97712,08610,9439,91710,0588,990
Accrued Expenses
92.88536.83604.96640.01564.03514.43
Short-Term Debt
349.76485.06268.35252.06428.83471.83
Current Portion of Leases
93.09100.274.0880.575.8170.12
Current Income Taxes Payable
294.7687.49113.1784.89112.1876.99
Current Unearned Revenue
177.72275.2561.12176.943.6866.59
Other Current Liabilities
1,2151,2851,8301,5891,4571,047
Total Current Liabilities
14,20114,85613,89412,74012,73911,237
Long-Term Leases
208.76260.69205.08182.57197.29260.09
Long-Term Unearned Revenue
35.3538.7946.0646.3542.6645.53
Pension & Post-Retirement Benefits
0.270.270.440.450.540.69
Long-Term Deferred Tax Liabilities
18.8924.1926.7833.4735.3940.84
Other Long-Term Liabilities
730.63773.55747.14747.14639.8226.62
Total Liabilities
15,19415,95314,92013,75013,65511,811
Common Stock
754.5754.5754.5754.5754.5754.5
Additional Paid-In Capital
2,3492,3492,3492,3492,3492,349
Retained Earnings
14,88613,99712,64211,0879,6528,312
Comprehensive Income & Other
53.1427.2830.7424.0424.9127.69
Total Common Equity
18,04317,12815,77614,21512,78011,444
Minority Interest
1,8881,8471,7571,6451,5751,650
Shareholders' Equity
19,93118,97517,53315,85914,35513,094
Total Liabilities & Equity
35,12534,92832,45329,60928,01024,905
Total Debt
651.61845.95547.5515.13701.93802.04
Net Cash (Debt)
7,07510,04010,3788,3816,6145,423
Net Cash Growth
-7.32%-3.26%23.83%26.72%21.97%5.41%
Net Cash Per Share
9.3813.3113.7611.118.777.19
Filing Date Shares Outstanding
754.5754.5754.5754.5754.5754.5
Total Common Shares Outstanding
754.5754.5754.5754.5754.5754.5
Working Capital
16,32815,50114,38513,02511,84510,872
Book Value Per Share
23.9122.7020.9118.8416.9415.17
Tangible Book Value
17,58516,64815,31413,74812,31810,984
Tangible Book Value Per Share
23.3122.0620.3018.2216.3314.56
Buildings
-408.84408.84433.49387.18381.37
Machinery
-802.66759.8702.78661.15629.64
Construction In Progress
-0.572.5436.2157.0913.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.